연구동향 분석

Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection

오은지 박혜원 박경운 강은숙 김현숙 송은영 2015년

논문상세정보
인용/피인용
' Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • antibody specificity
  • concordance
  • correlation
  • histocompatibilitytesting
  • hlaantigens
  • laboratories
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,133 0

0.0%

' Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection' 의 참고문헌

  • The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
    Loupy A Nat Rev Nephrol 8 : 348 ~ 357
  • The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
    Loupy A Nat Rev Nephrol 8 348-357 [2012]
  • Summary of FDA antibody-mediated rejection workshop
    Archdeacon P Am J Transplant 11 : 896 ~ 906 [2011]
  • Summary of FDA antibody-mediated rejection workshop
    Archdeacon P Am J Transplant 11 896-906 [2011]
  • Strategies for human leukocyte antigen antibody detection
    Bray RA Curr Opin Organ Transplant 14 : 392 ~ 397 [2009]
  • Strategies for human leukocyte antigen antibody detection
    Bray RA Curr Opin Organ Transplant 14 392-397 [2009]
  • Solid phase HLA antibody detection technology–challenges in interpretation
    Tait BD Tissue Antigens 76 : 87 ~ 95 [2010]
  • Solid phase HLA antibody detection technology–challenges in interpretation
    Tait BD Tissue Antigens 76 87-95 [2010]
  • Quantifying HLA-specific antibodies in patients undergoingdesensitization
    Zachary A CurrOpinOrgan Transplant 16 : 410 ~ 415 [2011]
  • Quantifying HLA-specific antibodies in patients undergoingdesensitization
    Zachary A CurrOpinOrgan Transplant 16 410-415 [2011]
  • Perception versus reality?: virtual crossmatch–how to overcome some of the technical and logistic limitations
    Tambur AR Am J Transplant 9 : 1886 ~ 1893 [2009]
  • Perception versus reality?: virtual crossmatch–how to overcome some of the technical and logistic limitations
    Tambur AR Am J Transplant 9 1886-1893 [2009]
  • Nothing’s perfect: the art of defining HLA-specific antibodies
    Middleton D Transplant Immunol 30 : 115 ~ 121 [2014]
  • Nothing’s perfect: the art of defining HLA-specific antibodies
    Middleton D Transplant Immunol 30 115-121 [2014]
  • Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant
    Aubert V Hum Immunol 70 : 580 ~ 583 [2009]
  • Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant
    Aubert V Hum Immunol 70 580-583 [2009]
  • Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay
    Gandhi MJ Transfusion 53 : 1940 ~ 1947 [2013]
  • Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay
    Gandhi MJ Transfusion 53 1940-1947 [2013]
  • Investigations into the lack of consensus in the reporting of HLA antibody specificities in the UK
    Wortley A J Clin Pathol 62 : 270 ~ 274 [2009]
  • Investigations into the lack of consensus in the reporting of HLA antibody specificities in the UK
    Wortley A J Clin Pathol 62 270-274 [2009]
  • Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay
    Gandhi MJ Hum Immunol 74 : 310 ~ 317 [2013]
  • Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay
    Gandhi MJ Hum Immunol 74 310-317 [2013]
  • Increasing relevance of donor-specific antibodies in antibody-mediated rejection
    Zito A J Nephrol 26 : 237 ~ 242 [2013]
  • Increasing relevance of donor-specific antibodies in antibody-mediated rejection
    Zito A J Nephrol 26 237-242 [2013]
  • Histocompatibility considerations for kidney paired donor exchange programs
    Murphey CL Curr Opin Organ Transplant 17 : 427 ~ 432 [2012]
  • Histocompatibility considerations for kidney paired donor exchange programs
    Murphey CL Curr Opin Organ Transplant 17 427-432 [2012]
  • Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation
    Liu C Hum Immunol 73 : 597 ~ 604 [2012]
  • Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation
    Liu C Hum Immunol 73 597-604 [2012]
  • Current methodologies for detecting sensitization to HLA antigens
    Cecka JM Curr Opin Organ Transplant 16 : 398 ~ 403 [2011]
  • Current methodologies for detecting sensitization to HLA antigens
    Cecka JM Curr Opin Organ Transplant 16 398-403 [2011]
  • Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation
    Tait BD Transplantation 95 : 19 ~ 47 [2013]
  • Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation
    Tait BD Transplantation 95 19-47 [2013]
  • Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA
    Reed EF Am J Transplant 13 : 1859 ~ 1870 [2013]
  • Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA
    Reed EF Am J Transplant 13 1859-1870 [2013]
  • Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
    Waiser J Nephrol Dial Transplant 27 : 1246 ~ 1251 [2012]
  • Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
    Waiser J Nephrol Dial Transplant 27 1246-1251 [2012]
  • Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
    송은영 Annals of Laboratory Medicine 32 (2) : 139 ~ 144 [2012]
  • Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
    송은영 Annals of Laboratory Medicine 32 2 139-144 [2012]
  • Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation
    Gloor JM Am J Transplant 10 : 582 ~ 589 [2010]
  • Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation
    Gloor JM Am J Transplant 10 582-589 [2010]
  • Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation
    Burns JM Am J Transplant 8 : 2684 ~ 2694 [2008]
  • Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation
    Burns JM Am J Transplant 8 2684-2694 [2008]
  • Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
    Reinsmoen NL Transplantation 86 : 820 ~ 825 [2008]
  • Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
    Reinsmoen NL Transplantation 86 820-825 [2008]